Suppr超能文献

将临床药师整合到物质使用障碍强化门诊治疗计划中,以提高酒精使用障碍药物治疗的处方率。

Integration of a clinical pharmacy specialist into a substance use disorder intensive outpatient treatment program to improve prescribing rates of alcohol use disorder pharmacotherapy.

机构信息

a All authors are affiliated with the Minneapolis Veterans Affairs Health Care System in Minneapolis, Minneapolis MN.

出版信息

Subst Abus. 2018;39(2):190-192. doi: 10.1080/08897077.2018.1449172.

Abstract

BACKGROUND

Research has demonstrated that the combination of pharmacotherapy and psychological interventions in alcohol use disorder (AUD) treatment is superior to either alone. Despite this, medications remain highly underutilized in many outpatient treatment facilities. Pharmacists can serve as an excellent resource to aid in improving access to medications.

METHODS

This study was a prospective, longitudinal evaluation of a pharmacist's role in a substance use disorder (SUD) clinic, specifically an intensive outpatient program (IOP). The primary objective was to determine if the addition of a clinical pharmacy specialist (CPS) as a bridge until next available provider appointment would improve access to AUD pharmacotherapy for patients in the IOP.

RESULTS

A total of 43 patients were enrolled in the IOP during the study. Of these, 27 patients presented with a primary diagnosis of AUD, and only eight were receiving AUD pharmacotherapy at the start of the program. During this intervention, 11 patients expressed interest in initiating a medication for AUD while in the IOP. The average wait time for a medication evaluation appointment with the CPS was 1.4 days. By comparison, the average wait time for an addiction psychiatrist was approximately 44 days. Each patient was seen for an average of two 30-minute visits, including an initial medication evaluation and one follow-up. Upon completion of CPS services, patients were referred almost equally to an established non-addiction recovery services (ARS) mental health provider (36%), an ARS psychiatrist (36%), or a primary care provider (28%).

CONCLUSION

Our study highlights the role that pharmacists can play in improving access to evidence-based AUD pharmacotherapy, as well as in providing medication education to patients and providers. Long-term prospective research and pharmacoeconomic analysis are needed to determine the sustainability of this service, both at our facility and in other similar practice settings.

摘要

背景

研究表明,药物治疗与心理干预相结合治疗酒精使用障碍(AUD)优于单一治疗。尽管如此,许多门诊治疗机构仍严重低估了药物的作用。药剂师可以成为一个很好的资源,帮助改善药物的获取。

方法

本研究是对药剂师在物质使用障碍(SUD)诊所,特别是强化门诊项目(IOP)中的作用的前瞻性、纵向评估。主要目的是确定在有资质的治疗师预约之前,增加临床药师专家(CPS)作为桥梁,是否可以改善 IOP 中 AUD 药物治疗的可及性。

结果

在研究期间,共有 43 名患者入组 IOP。其中,27 名患者的主要诊断为 AUD,而在项目开始时只有 8 名患者正在接受 AUD 药物治疗。在此干预期间,11 名患者表示有兴趣在 IOP 中开始使用一种治疗 AUD 的药物。与 CPS 预约药物评估的平均等待时间为 1.4 天。相比之下,成瘾精神病医生的平均等待时间约为 44 天。每位患者平均接受了两次 30 分钟的就诊,包括初始药物评估和一次随访。完成 CPS 服务后,患者被转诊至建立的非成瘾康复服务(ARS)心理健康提供者(36%)、ARS 精神科医生(36%)或初级保健提供者(28%)的比例几乎相等。

结论

我们的研究强调了药剂师在改善基于证据的 AUD 药物治疗可及性方面可以发挥的作用,以及为患者和提供者提供药物教育的作用。需要进行长期的前瞻性研究和药物经济学分析,以确定这种服务的可持续性,包括在我们的机构和其他类似的实践环境中。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验